Literature DB >> 27305837

A Requirement for Metamorphic Interconversion in the Antimicrobial Activity of Chemokine XCL1.

Amanda M Nevins1, Akshay Subramanian2, Jazma L Tapia2, David P Delgado2, Robert C Tyler1, Davin R Jensen1, André J Ouellette2, Brian F Volkman1.   

Abstract

Chemokines make up a superfamily of ∼50 small secreted proteins (8-12 kDa) involved in a host of physiological processes and disease states, with several previously shown to have direct antimicrobial activity comparable to that of defensins in efficacy. XCL1 is a unique metamorphic protein that interconverts between the canonical chemokine fold and a novel all-β-sheet dimer. Phylogenetic analysis suggests that, within the chemokine family, XCL1 is most closely related to CCL20, which exhibits antibacterial activity. The in vitro antimicrobial activity of WT-XCL1 and structural variants was quantified using a radial diffusion assay (RDA) and in solution bactericidal assays against Gram-positive and Gram-negative species of bacteria. Comparisons of WT-XCL1 with variants that limit metamorphic interconversion showed a loss of antimicrobial activity when restricted to the conserved chemokine fold. These results suggest that metamorphic folding of XCL1 is required for potent antimicrobial activity.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27305837      PMCID: PMC6956654          DOI: 10.1021/acs.biochem.6b00353

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

2.  Antibiotic resistance: the last resort.

Authors:  Maryn McKenna
Journal:  Nature       Date:  2013-07-25       Impact factor: 49.962

3.  Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43 down arrow ILE44 proteolysis enables membrane-disruptive activity.

Authors:  Colby S Weeks; Hiroki Tanabe; Jason E Cummings; Steve P Crampton; Tanya Sheynis; Raz Jelinek; T Kyle Vanderlick; Melanie J Cocco; Andre J Ouellette
Journal:  J Biol Chem       Date:  2006-07-05       Impact factor: 5.157

Review 4.  Chemokine: receptor structure, interactions, and antagonism.

Authors:  Samantha J Allen; Susan E Crown; Tracy M Handel
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

5.  Criterion for amino acid composition of defensins and antimicrobial peptides based on geometry of membrane destabilization.

Authors:  Nathan W Schmidt; Abhijit Mishra; Ghee Hwee Lai; Matthew Davis; Lori K Sanders; Dat Tran; Angie Garcia; Kenneth P Tai; Paul B McCray; André J Ouellette; Michael E Selsted; Gerard C L Wong
Journal:  J Am Chem Soc       Date:  2011-04-07       Impact factor: 15.419

6.  Many chemokines including CCL20/MIP-3alpha display antimicrobial activity.

Authors:  De Yang; Qian Chen; David M Hoover; Patricia Staley; Kenneth D Tucker; Jacek Lubkowski; Joost J Oppenheim
Journal:  J Leukoc Biol       Date:  2003-09       Impact factor: 4.962

7.  Interconversion between two unrelated protein folds in the lymphotactin native state.

Authors:  Robbyn L Tuinstra; Francis C Peterson; Snjezana Kutlesa; E Sonay Elgin; Michael A Kron; Brian F Volkman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-25       Impact factor: 11.205

8.  Rhesus macaque theta defensins suppress inflammatory cytokines and enhance survival in mouse models of bacteremic sepsis.

Authors:  Justin B Schaal; Dat Tran; Patti Tran; George Ösapay; Katie Trinh; Kevin D Roberts; Kathleen M Brasky; Prasad Tongaonkar; André J Ouellette; Michael E Selsted
Journal:  PLoS One       Date:  2012-12-06       Impact factor: 3.240

9.  Structural perspectives on antimicrobial chemokines.

Authors:  Leonard T Nguyen; Hans J Vogel
Journal:  Front Immunol       Date:  2012-12-28       Impact factor: 7.561

10.  Antimicrobial peptides design by evolutionary multiobjective optimization.

Authors:  Giuseppe Maccari; Mariagrazia Di Luca; Riccardo Nifosí; Francesco Cardarelli; Giovanni Signore; Claudia Boccardi; Angelo Bifone
Journal:  PLoS Comput Biol       Date:  2013-09-05       Impact factor: 4.475

View more
  12 in total

1.  Complement factor P: promoting the antibacterial activity of natural killer cells.

Authors:  Xiaoxuan Zhuang; Eric O Long
Journal:  Cell Mol Immunol       Date:  2017-07-24       Impact factor: 11.530

2.  Clinical importance of chemokines and inflammatory cytokines for patient care following percutaneous nephrolithotripsy.

Authors:  Junrong Wang; Wei Wang; Wei Guo; Yanru Ma; Tianhui Ji; Baodi Zhang
Journal:  Exp Ther Med       Date:  2017-12-15       Impact factor: 2.447

3.  Specific binding-induced modulation of the XCL1 metamorphic equilibrium.

Authors:  Acacia F Dishman; Francis C Peterson; Brian F Volkman
Journal:  Biopolymers       Date:  2020-09-28       Impact factor: 2.505

4.  Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.

Authors:  Laurent Gauthier; Myriam Baratin; Sophie Guia; Aurore Fenis; Emilie Narni-Mancinelli; Ala-Eddine Deghmane; Benjamin Rossi; Patrick Fourquet; Bertrand Escalière; Yann M Kerdiles; Sophie Ugolini; Muhamed-Kheir Taha; Eric Vivier
Journal:  Sci Immunol       Date:  2017-04-28

5.  Chemokine CCL28 Is a Potent Therapeutic Agent for Oropharyngeal Candidiasis.

Authors:  Jie He; Monica A Thomas; Jaime de Anda; Michelle W Lee; Emma Van Why; Pippa Simpson; Gerard C L Wong; Mitchell H Grayson; Brian F Volkman; Anna R Huppler
Journal:  Antimicrob Agents Chemother       Date:  2020-07-22       Impact factor: 5.191

Review 6.  Unfolding the Mysteries of Protein Metamorphosis.

Authors:  Acacia F Dishman; Brian F Volkman
Journal:  ACS Chem Biol       Date:  2018-06-07       Impact factor: 5.100

7.  Evolution of fold switching in a metamorphic protein.

Authors:  Acacia F Dishman; Robert C Tyler; Jamie C Fox; Andrew B Kleist; Kenneth E Prehoda; M Madan Babu; Francis C Peterson; Brian F Volkman
Journal:  Science       Date:  2021-01-01       Impact factor: 47.728

Review 8.  NK Cells in Chronic Lymphocytic Leukemia and Their Therapeutic Implications.

Authors:  Paolo Sportoletti; Filomena De Falco; Beatrice Del Papa; Stefano Baldoni; Valerio Guarente; Andrea Marra; Erica Dorillo; Chiara Rompietti; Francesco Maria Adamo; Loredana Ruggeri; Mauro Di Ianni; Emanuela Rosati
Journal:  Int J Mol Sci       Date:  2021-06-22       Impact factor: 5.923

9.  Metamorphic Protein Folding Encodes Multiple Anti-Candida Mechanisms in XCL1.

Authors:  Acacia F Dishman; Jie He; Brian F Volkman; Anna R Huppler
Journal:  Pathogens       Date:  2021-06-17

10.  Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1.

Authors:  Acacia F Dishman; Michelle W Lee; Jaime de Anda; Ernest Y Lee; Jie He; Anna R Huppler; Gerard C L Wong; Brian F Volkman
Journal:  ACS Infect Dis       Date:  2020-04-15       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.